Literature DB >> 27022318

Transfusion Support for ABO-Incompatible Progenitor Cell Transplantation.

Patricia M Kopko1.   

Abstract

ABO-incompatible transplants comprise up to 50% of allogeneic progenitor cell transplants. Major, minor and bidirectional ABO-incompatible transplants each have unique complications that can occur, including hemolysis at the time of progenitor cell infusion, hemolysis during donor engraftment, passenger lymphocyte syndrome, delayed red blood cell engraftment, and pure red cell aplasia. Appropriate transfusion support during the different phases of the allogeneic progenitor cell transplant process is an important part of ABO-incompatible transplantation.

Entities:  

Keywords:  ABO-incompatible transplant; Platelet transfusion; Transfusion

Year:  2015        PMID： 27022318      PMCID： PMC4797464          DOI： 10.1159/000441612

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN： 1660-3796            Impact factor:   3.747


  16 in total

1.  AB0-incompatible allogeneic hematopoietic stem cell transplantation.

Authors:  Nina Worel; Peter Kalhs
Journal:  Haematologica       Date:  2008-11       Impact factor: 9.941

2.  Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue.

Authors:  Joseph Schwartz; Jeffrey L Winters; Anand Padmanabhan; Rasheed A Balogun; Meghan Delaney; Michael L Linenberger; Zbigniew M Szczepiorkowski; Mark E Williams; Yanyun Wu; Beth H Shaz
Journal:  J Clin Apher       Date:  2013-07       Impact factor: 2.821

3.  A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies.

Authors:  Karen Quillen; Sherry L Sheldon; Jennifer A Daniel-Johnson; A Hallie Lee-Stroka; Willy A Flegel
Journal:  Transfusion       Date:  2011-01       Impact factor: 3.157

4.  Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.

Authors:  Nina Worel; Hildegard T Greinix; Felix Keil; Margit Mitterbauer; Klaus Lechner; Gottfried Fischer; Wolfgang Mayr; Paul Höcker; Peter Kalhs
Journal:  Transfusion       Date:  2002-10       Impact factor: 3.157

5.  Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation.

Authors:  C D Bolan; S F Leitman; L M Griffith; R A Wesley; J L Procter; D F Stroncek; A J Barrett; R W Childs
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

Review 6.  Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation.

Authors:  S D Rowley; M L Donato; P Bhattacharyya
Journal:  Bone Marrow Transplant       Date:  2011-09       Impact factor: 5.483

7.  ABO blood group antigens on human plasma von Willebrand factor after ABO-mismatched bone marrow transplantation.

Authors:  T Matsui; T Shimoyama; M Matsumoto; Y Fujimura; Y Takemoto; M Sako; J Hamako; K Titani
Journal:  Blood       Date:  1999-10-15       Impact factor: 22.113

8.  Clinical outcomes of ABO-incompatible RBC transfusions.

Authors:  Kim A Janatpour; Norman D Kalmin; Hanne M Jensen; Paul V Holland
Journal:  Am J Clin Pathol       Date:  2008-02       Impact factor: 2.493

9.  Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.

Authors:  Nina Worel; Hildegard T Greinix; Volker Supper; Gerda Leitner; Margit Mitterbauer; Werner Rabitsch; Gottfried Fischer; Agathe Rosenmayr; Paul Höcker; Peter Kalhs
Journal:  Transfusion       Date:  2007-08       Impact factor: 3.157

10.  Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants.

Authors:  Robyn Cunard; Isagani I Marquez; Edward D Ball; Connie L Nelson; Sue Corringham; Paul Clopton; Amber P Sanchez; Thomas Lane; David M Ward
Journal:  Transfusion       Date:  2013-12-24       Impact factor: 3.157
View more
  4 in total

1.  In vivo Adsorption of Isoagglutinins with Incompatible Red Blood Cell Transfusion in Stem Cell Transplant Recipients.

Authors:  Rainer Moog
Journal:  Transfus Med Hemother       Date:  2016-07-18       Impact factor: 3.747

2.  Haemolysis, pure red cell aplasia and red cell antibody formation associated with major and bidirectional ABO incompatible haematopoietic stem cell transplantation.

Authors:  Gordana Tomac; Ines Bojanić; Sanja Mazić; Ivana Vidović; Mirela Raos; Branka Golubić Ćepulić; Ranka Serventi Seiwerth; Jadranka Kelečić; Boris Labar
Journal:  Blood Transfus       Date:  2017-04-19       Impact factor: 3.443

Review 3.  [When A is not A anymore: problems and pitfalls with blood group typing].

Authors:  P Möhnle; A Humpe; G Wittmann
Journal:  Anaesthesist       Date:  2018-09       Impact factor: 1.041

4.  Choice of ABO Group for Blood Component Transfusion in ABO-Incompatible Solid Organ Transplantation: A Questionnaire Survey in Korea and Guideline Proposal.

Authors:  Yousun Chung; Dae-Hyun Ko; Jihyang Lim; Kyeong-Hee Kim; Hyungsuk Kim
Journal:  Ann Lab Med       Date:  2022-01-01       Impact factor: 3.464
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.